Related references
Note: Only part of the references are listed.Mouse models of aneuploidy to understand chromosome disorders
Justin Tosh et al.
MAMMALIAN GENOME (2022)
Cryo-EM structures of amyloid-b 42 filaments from human brains
Yang Yang et al.
SCIENCE (2022)
Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome
Jerzy Wegiel et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)
Temporal and brain region-specific elevations of soluble Amyloid-β40-42 in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease
Savannah Tallino et al.
AGING CELL (2022)
The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice
Md Mahiuddin Ahmed et al.
NEUROBIOLOGY OF DISEASE (2022)
USP25 inhibition ameliorates Alzheimer's pathology through the regulation of APP processing and Aβ generation
Qiuyang Zheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model
Xu-Qiao Chen et al.
ALZHEIMERS & DEMENTIA (2021)
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng et al.
NATURE REVIEWS NEUROLOGY (2021)
Trisomy 21-induced dysregulation of microglial homeostasis in Alzheimer's brains is mediated by USP25
Qiuyang Zheng et al.
SCIENCE ADVANCES (2021)
Endosome Dysregulation in Down Syndrome: A Potential Contributor to Alzheimer Disease Pathology
Alessia Filippone et al.
ANNALS OF NEUROLOGY (2021)
Alzheimer's disease associated with Down syndrome: a genetic form of dementia
Juan Fortea et al.
LANCET NEUROLOGY (2021)
Altered cell and RNA isoform diversity in aging Down syndrome brains
Carter R. Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Tau assemblies do not behave like independently acting prion-like particles in mouse neural tissue
Lauren V. C. Miller et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome
Veronique Brault et al.
PLOS GENETICS (2021)
Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer's disease-like pathology
David Baglietto-Vargas et al.
NATURE COMMUNICATIONS (2021)
Microglial identity and inflammatory responses are controlled by the combined effects of neurons and astrocytes
Paul S. Baxter et al.
CELL REPORTS (2021)
Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer's Disease
Veronica Vidal et al.
FRONTIERS IN PHARMACOLOGY (2021)
Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome
Victor Montal et al.
ANNALS OF NEUROLOGY (2021)
Comprehensive phenotypic analysis of the Dp1Tyb mouse strain reveals a broad range of Down syndrome-related phenotypes
Eva Lana-Elola et al.
DISEASE MODELS & MECHANISMS (2021)
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study
Anne M. Fagan et al.
LANCET NEUROLOGY (2021)
Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer's Disease
Melissa J. Alldred et al.
MOLECULAR NEUROBIOLOGY (2021)
Astrocytes in Down Syndrome Across the Lifespan
Blandine Ponroy Bally et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
Association of Apolipoprotein E ε4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
Alexandre Bejanin et al.
JAMA NEUROLOGY (2021)
APOE ε4 Association With Cognition and Alzheimer Disease Biomarkers in Down Syndrome-Implications for Clinical Trials and Treatments for All
Cynthia A. Lemere et al.
JAMA NEUROLOGY (2021)
Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome
Tomer Illouz et al.
FRONTIERS IN IMMUNOLOGY (2021)
Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain
Aurelie Ledreux et al.
JOURNAL OF CLINICAL MEDICINE (2021)
The Association between Sex and Risk of Alzheimer's Disease in Adults with Down Syndrome
Pooja Girish Mhatre et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity
Miren Altuna et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer's disease
Dimitrios Sideris et al.
BRAIN COMMUNICATIONS (2021)
Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey
Anke Huls et al.
ECLINICALMEDICINE (2021)
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
Tobey J. Betthauser et al.
BRAIN (2020)
RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome
Eric D. Hamlett et al.
GLIA (2020)
An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report
Grace E. Weber et al.
JOURNAL OF IMMUNOLOGY (2020)
Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia
Asta Luciunaite et al.
JOURNAL OF NEUROCHEMISTRY (2020)
Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome
Eric D. Hamlett et al.
NEUROBIOLOGY OF DISEASE (2020)
microRNAs expression correlates with levels of APP, DYRK1A, hyperphosphorylated Tau and BDNF in the hippocampus of a mouse model for Down syndrome during ageing
Juliana C. S. Chaves et al.
NEUROSCIENCE LETTERS (2020)
Hallmarks of NLRP3 inflammasome activation are observed in organotypic hippocampal slice culture
Christopher Hoyle et al.
IMMUNOLOGY (2020)
Down syndrome
Stylianos E. Antonarakis et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Immune Dysregulation in Children With Down Syndrome
Dean Huggard et al.
FRONTIERS IN PEDIATRICS (2020)
A non-mosaic transchromosomic mouse model of down syndrome carrying the long arm of human chromosome 21
Yasuhiro Kazuki et al.
ELIFE (2020)
Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome
Alexandra Botte et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Longitudinal neuroanatomical and behavioral analyses show phenotypic drift and variability in the Ts65Dn mouse model of Down syndrome
Patricia R. Shaw et al.
DISEASE MODELS & MECHANISMS (2020)
Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease
Lutgarde Serneels et al.
MOLECULAR NEURODEGENERATION (2020)
Rescuing Over-activated Microglia Restores Cognitive Performance in Juvenile Animals of the Dp(16) Mouse Model of Down Syndrome
Bruno Pinto et al.
NEURON (2020)
Evolution of neuroinflammation across the lifespan of individuals with Down syndrome
Lisi Flores-Aguilar et al.
BRAIN (2020)
Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue
L. Lemoine et al.
MOLECULAR NEURODEGENERATION (2020)
Organotypic Brain Slice Culture Microglia Exhibit Molecular Similarity to Acutely-Isolated Adult Microglia and Provide a Platform to Study Neuroinflammation
Alex R. D. Delbridge et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Sex differences in risk of Alzheimer's disease in adults with Down syndrome
Florence Lai et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome
Alessandra C. Martini et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
Amyloid accumulation in Down syndrome measured with amyloid load
Matthew D. Zammit et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome
Kathryn D. Tuttle et al.
CELL REPORTS (2020)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease
Carla M. Startin et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
Fabio Di Domenico et al.
REDOX BIOLOGY (2019)
Lipopolysaccharide-induced neuroinflammation induces presynaptic disruption through a direct action on brain tissue involving microglia-derived interleukin 1 beta
Olivia Sheppard et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99)
Ying Jiang et al.
JOURNAL OF NEUROSCIENCE (2019)
Tau binding protein CAPON induces tau aggregation and neurodegeneration
Shoko Hashimoto et al.
NATURE COMMUNICATIONS (2019)
Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus
Simone Granno et al.
SCIENTIFIC REPORTS (2019)
Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome
Carla M. Startin et al.
ALZHEIMERS & DEMENTIA (2019)
Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse model
Tomer Illouz et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome
Michael S. Rafii
DEVELOPMENTAL NEUROBIOLOGY (2019)
Copper accumulation in the brain causes the elevation of oxidative stress and less anxious behavior in Ts1Cje mice, a model of Down syndrome
Keiichi Ishihara et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Large-scale discovery of mouse transgenic integration sites reveals frequent structural variation and insertional mutagenesis
Leslie O. Goodwin et al.
GENOME RESEARCH (2019)
Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease
Alex M. Helman et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Mouse Genome Database (MGD) 2019
Carol J. Bult et al.
NUCLEIC ACIDS RESEARCH (2019)
Organotypic brain slice cultures to model neurodegenerative proteinopathies
C. L. Croft et al.
MOLECULAR NEURODEGENERATION (2019)
Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years
Rosalyn Hithersay et al.
JAMA NEUROLOGY (2019)
Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome
Amanda Sinai et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
In vivo and ex vivo analyses of amyloid toxicity in the Tc1 mouse model of Down syndrome
Gaelle Naert et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease
David M. A. Mann et al.
ACTA NEUROPATHOLOGICA (2018)
PET staging of amyloidosis using striatum
Bernard J. Hanseeuw et al.
ALZHEIMERS & DEMENTIA (2018)
Trisomy of human chromosome 21 enhances amyloid-beta deposition independently of an extra copy of APP
Frances K. Wiseman et al.
BRAIN (2018)
Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice
Noemi Rueda et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Early and Selective Activation and Subsequent Alterations to the Unfolded Protein Response in Down Syndrome Mouse Models
Chiara Lanzillotta et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Developmental excitatory-to-inhibitory GABA polarity switch is delayed in Ts65Dn mice, a genetic model of Down syndrome
Larisa V. Lysenko et al.
NEUROBIOLOGY OF DISEASE (2018)
Extracellular Forms of A beta and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic Plasticity
Neng-Wei Hu et al.
CELL REPORTS (2018)
The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome
Yvonne S. Davidson et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
ALZHEIMER DISEASE Rodent models for Alzheimer disease
Juergen Goetz et al.
NATURE REVIEWS NEUROSCIENCE (2018)
Neural blastocyst complementation enables mouse forebrain organogenesis
Amelia N. Chang et al.
NATURE (2018)
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
Antonella Tramutola et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Estimation of the number of people with Down syndrome in the United States
Gert de Graaf et al.
GENETICS IN MEDICINE (2017)
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)
Michael S. Rafii et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP
Eric Doran et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Practical considerations for choosing a mouse model of Alzheimer's disease
Joanna L. Jankowsky et al.
MOLECULAR NEURODEGENERATION (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Age exacerbates abnormal protein expression in a mouse model of Down syndrome
Md. Mahiuddin Ahmed et al.
NEUROBIOLOGY OF AGING (2017)
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome
Fiorenza Stagni et al.
NEUROBIOLOGY OF DISEASE (2017)
Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes
Susana Garcia-Cerro et al.
NEUROBIOLOGY OF DISEASE (2017)
Presenilin-1 mutations and Alzheimer's disease
Raymond J. Kelleher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome
Andrea Contestabile et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Membrane association and release of wild-type and pathological tau from organotypic brain slice cultures
Cara L. Croft et al.
CELL DEATH & DISEASE (2017)
Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
Johannes Steffen et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Elizabeth Head et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice
Xiaomin Yin et al.
SCIENTIFIC REPORTS (2017)
Comparative profiling of cortical gene expression in Alzheimer's disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
Erika Castillo et al.
SCIENTIFIC REPORTS (2017)
Rodent models in Down syndrome research: impact and future opportunities
Yann Herault et al.
DISEASE MODELS & MECHANISMS (2017)
A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome
M. McCarron et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2017)
Amyloid beta: structure, biology and structure-based therapeutic development
Guo-fang Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Cognitive decline and dementia in Down syndrome
Rosalyn Hithersay et al.
CURRENT OPINION IN PSYCHIATRY (2017)
Organotypic Hippocampal Slices as Models for Stroke and Traumatic Brain Injury
Qian Li et al.
MOLECULAR NEUROBIOLOGY (2016)
Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease
S. Kim et al.
MOLECULAR PSYCHIATRY (2016)
Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway
Utpal Das et al.
NATURE NEUROSCIENCE (2016)
The pattern of amyloid accumulation in the brains of adults with Down syndrome
Tiina Annus et al.
ALZHEIMERS & DEMENTIA (2016)
Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms
Amelia J. Anderson-Mooney et al.
BRAIN AND COGNITION (2016)
The Cellular Phase of Alzheimer's Disease
Bart De Strooper et al.
CELL (2016)
Experience-dependent reduction of soluble β-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome
Gabriele Sansevero et al.
EXPERIMENTAL NEUROLOGY (2016)
Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration
Wei Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Improved Survival in Down Syndrome over the Last 60 Years and the Impact of Perinatal Factors in Recent Decades
Emma J. Glasson et al.
JOURNAL OF PEDIATRICS (2016)
Synaptophysin depletion and intraneuronal Aβ in organotypic hippocampal slice cultures from huAPP transgenic mice
Claire S. Harwell et al.
MOLECULAR NEURODEGENERATION (2016)
Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF
Ying Jiang et al.
NEUROBIOLOGY OF AGING (2016)
Increases of SET level and translocation are correlated with tau hyperphosphorylation at ser202/thr205 in CA1 of Ts65Dn mice
Emilie Dorard et al.
NEUROBIOLOGY OF AGING (2016)
An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome
Pavel V. Belichenko et al.
PLOS ONE (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
Genetic dissection of Down syndrome-associated congenital heart defects using a new mouse mapping panel
Eva Lana-Elola et al.
ELIFE (2016)
1H-MRS metabolites in adults with Down syndrome: Effects of dementia
A. -L. Lin et al.
NEUROIMAGE-CLINICAL (2016)
Prevention and Periodontal Treatment in Down Syndrome Patients: A Systematic Review
Rafael Ferreira et al.
PLOS ONE (2016)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Frances K. Wiseman et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease
Donna M. Wilcock et al.
NEUROBIOLOGY OF AGING (2015)
Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging
B. Ghetti et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
Analysis of Adult Cerebral Cortex and Hippocampus Transcriptomes Reveals Unique Molecular Changes in the Ts1Cje Mouse Model of Down Syndrome
Faycal Guedj et al.
BRAIN PATHOLOGY (2015)
Nerve growth factor metabolic dysfunction in Down's syndrome brains
M. Florencia Iulita et al.
BRAIN (2014)
Sex Differences in the Cholinergic Basal Forebrain in the Ts65Dn Mouse Model of Down Syndrome and Alzheimer's Disease
Christy M. Kelley et al.
BRAIN PATHOLOGY (2014)
A cross-sectional analysis of otitis media with effusion in children with Down syndrome
M. Maris et al.
EUROPEAN JOURNAL OF PEDIATRICS (2014)
Single App knock-in mouse models of Alzheimer's disease
Takashi Saito et al.
NATURE NEUROSCIENCE (2014)
Microglial priming in neurodegenerative disease
V. Hugh Perry et al.
NATURE REVIEWS NEUROLOGY (2014)
A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome
M. McCarron et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2014)
The population prevalence of Down's syndrome in England and Wales in 2011
Jianhua Wu et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain
Md. Mahiuddin Ahmed et al.
HUMAN MOLECULAR GENETICS (2013)
Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome
Laureanne P. E. Lorenzo et al.
IMMUNOLOGY (2013)
Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A) Enhances Tau Expression
Wei Qian et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome
Andrea Corrales et al.
JOURNAL OF PINEAL RESEARCH (2013)
Massively Parallel Sequencing Reveals the Complex Structure of an Irradiated Human Chromosome on a Mouse Background in the Tc1 Model of Down Syndrome
Susan M. Gribble et al.
PLOS ONE (2013)
Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B
Benjamin L. Handen et al.
ALZHEIMERS & DEMENTIA (2012)
Size frequency distributions of β-amyloid (4β) deposits: a comparative study of four neurodegenerative disorders
Richard A. Armstrong
FOLIA NEUROPATHOLOGICA (2012)
Down Syndrome and Dementia: Seizures and Cognitive Decline
Ira T. Lott et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment
Lucilla Parnetti et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Altered regulation of tau phosphorylation in a mouse model of down syndrome aging
Olivia Sheppard et al.
NEUROBIOLOGY OF AGING (2012)
Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series
Daniel McNaughton et al.
NEUROBIOLOGY OF AGING (2012)
Role of common and rare APP DNA sequence variants in Alzheimer disease
B. V. Hooli et al.
NEUROLOGY (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Microglial pathology in Down syndrome
Qing-Shan Xue et al.
ACTA NEUROPATHOLOGICA (2011)
TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's Syndrome: association with age, hippocampal sclerosis and clinical phenotype
Yvonne S. Davidson et al.
ACTA NEUROPATHOLOGICA (2011)
Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome
Jason Lockrow et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Neural Stem Cells Reduce Hippocampal Tau and Reelin Accumulation in Aged Ts65Dn Down Syndrome Mice
D. S. Kern et al.
CELL TRANSPLANTATION (2011)
A Noradrenergic Lesion Exacerbates Neurodegeneration in a Down Syndrome Mouse Model
Jason Lockrow et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Characterization of Cortical Neuronal and Glial Alterations during Culture of Organotypic Whole Brain Slices from Neonatal and Mature Mice
Jerome A. Staal et al.
PLOS ONE (2011)
S100B and APP Promote a Gliocentric Shift and Impaired Neurogenesis in Down Syndrome Neural Progenitors
Jie Lu et al.
PLOS ONE (2011)
Behavioural Excesses and Deficits Associated with Dementia in Adults who have Down Syndrome
Chris Oliver et al.
JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES (2011)
A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions
Tao Yu et al.
HUMAN MOLECULAR GENETICS (2010)
Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP
Rita Joao Guerreiro et al.
NEUROBIOLOGY OF AGING (2010)
Lowering β-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model
William J. Netzer et al.
PLOS ONE (2010)
Alzheimer's-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition
Ying Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The First Confirmed Case of Down Syndrome with Dementia with Lewy Bodies
V. P. Prasher et al.
JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES (2010)
Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative Disease
Colm Cunningham et al.
BIOLOGICAL PSYCHIATRY (2009)
β-Amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice
Selene Lomoio et al.
BRAIN RESEARCH (2009)
Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model
Jason Lockrow et al.
EXPERIMENTAL NEUROLOGY (2009)
Down syndrome-recent progress and future prospects
Frances K. Wiseman et al.
HUMAN MOLECULAR GENETICS (2009)
Otitis media in a mouse model for Down syndrome
Fengchan Han et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model
Jennifer H. K. Choi et al.
JOURNAL OF NEUROCHEMISTRY (2009)
The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies
Jan O. Korbel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome
A. Salehi et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome
Fei Liu et al.
FASEB JOURNAL (2008)
Significant effect of APOE Epsilon 4 Genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down Syndrome
V. P. Prasher et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Protein expression of BACE1, BACE2 and APP in down syndrome brains
M. S. Cheon et al.
AMINO ACIDS (2008)
APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage
A. Rovelet-Lecrux et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models
Irene H. Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndrome
Jesse E. Hanson et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Systemic infections and inflammation affect chronic neurodegeneration
V. Hugh Perry et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current
Tyler K. Best et al.
JOURNAL OF NEUROPHYSIOLOGY (2007)
APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy
Kristel Sleegers et al.
BRAIN (2006)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Dementia and mortality in persons with Down's syndrome
A. Coppus et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2006)
Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome
Ebrahim Abdul Shukkur et al.
HUMAN MOLECULAR GENETICS (2006)
Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration
Ahmad Salehi et al.
NEURON (2006)
Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases
A Contestabile et al.
JOURNAL OF NEUROCHEMISTRY (2006)
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy
A Rovelet-Lecrux et al.
NATURE GENETICS (2006)
An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes
A O'Doherty et al.
SCIENCE (2005)
Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice
HY Seo et al.
EXPERIMENTAL NEUROLOGY (2005)
Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(1716)65Dn and mouse Chromosome 12
AJ Villar et al.
MAMMALIAN GENOME (2005)
Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons
IC Hellstrom et al.
HIPPOCAMPUS (2005)
Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen
CL Hunter et al.
NEUROBIOLOGY OF AGING (2004)
Minocycline prevents cholinergic loss in a mouse model of Down's syndrome
CL Hunter et al.
ANNALS OF NEUROLOGY (2004)
Cancers and immune related diseases associated with Down's syndrome: a record linkage study
MJ Goldacre et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2004)
Onset of dementia is associated with age at menopause in women with Down's syndrome
N Schupf et al.
ANNALS OF NEUROLOGY (2003)
Characteristic developmental expression of amyloid β40, 42 and 43 in patients with Down syndrome
A Hirayama et al.
BRAIN & DEVELOPMENT (2003)
Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome
HA Bimonte-Nelson et al.
BEHAVIOURAL BRAIN RESEARCH (2003)
Behavioral comparison of 4 and 6 month-old Ts65Dn mice: Age-related impairments in working and reference memory
CL Hunter et al.
BEHAVIOURAL BRAIN RESEARCH (2003)
Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome
ACE Granholm et al.
PHYSIOLOGY & BEHAVIOR (2002)
Cued recall in early-stage dementia in adults with Down's syndrome
DA Devenny et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2002)
Intraneuronal Aβ42 accumulation in Down syndrome brain
C Mori et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2002)
Characterization of two novel nuclear BTB/POZ domain zinc finger isoforms - Association with differentiation of hippocampal neurons, cerebellar granule cells, and macroglia
C Mitchelmore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Changes in explicit memory associated with early dementia in adults with Down's syndrome
SJ Krinsky-McHale et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2002)
Neurological changes and emotional functioning in adults with Down Syndrome
LD Nelson et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2001)
Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion
JD Cooper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Complement association with neurons and β-amyloid deposition in the brains of aged individuals with down syndrome
E Head et al.
NEUROBIOLOGY OF DISEASE (2001)
Nerve growth factor signaling, neuroprotection, and neural repair
MV Sofroniew et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice:: Synaptotoxicity without plaque formation
L Mucke et al.
JOURNAL OF NEUROSCIENCE (2000)
APOE ε4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome
S Deb et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease
SE Stoltzner et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome
ACE Granholm et al.
EXPERIMENTAL NEUROLOGY (2000)
Share Paper
